1.Apoptosis of Skeletal Muscle on Steroid-Induced Myopathy in Rats.
Myung Ju LEE ; Ji Shin LEE ; Min Cheol LEE
Journal of Korean Medical Science 2001;16(4):467-474
Recently apoptotic cell death has been reported in differentiated skeletal muscle, where apoptosis was generally assumed not to occur. To investigate whether apoptosis may contribute to the steroid-induced myopathy, rats treated with triamcinolone acetonide (TA) for 9 days were sacrificed for detecting apoptosis by in situ end labeling (ISEL) and electron microscopy in the soleus muscles. Immunohistochemical stainings of Fas antigen and p53 protein were performed to examine whether apoptosis-related proteins were present in the myopathy. Muscle fiber necrosis and apoptotic myonuclei appeared in the soleus muscles following administration of TA, while control muscles showed no evidences for apoptosis. Fas antigen was not detected in control muscles, but expressed in the soleus muscles of steroid-induced myopathy. Some of the Fas antigen-expressing muscle fibers were positive for ISEL. p53 protein was not detected in any muscle fibers. These findings indicate that TA can induce apoptosis in differentiated skeletal muscles, and Fas antigen might be partly related to apoptotic muscle death in steroid-induced myopathy.
Animal
;
Antigens, CD95/analysis
;
*Apoptosis
;
Female
;
Immunohistochemistry
;
Microscopy, Electron
;
Muscle, Skeletal/*pathology/ultrastructure
;
Muscular Diseases/chemically induced/*pathology
;
Protein p53/analysis
;
Rats
;
Rats, Sprague-Dawley
;
Triamcinolone Acetonide/*toxicity
2.Clinical Significances of Serum Soluble Fas and Soluble Fas Ligand in Chronic Hepatitis B.
Eun Jung JUN ; Joon Yeol HAN ; Hee Sik SUN
The Korean Journal of Hepatology 2006;12(4):507-514
BACKGROUND/AIMS: Apoptosis via Fas/FasL system is thought to be involved in the development of hepatocyte death in viral hepatitis B. In chronic hepatitis C, sFas/sFasL system was reported to control liver injury induced by Fas/FasL mediated apoptosis. To determine the role of sFas/sFasL system in chronic hepatitis B, we analyzed serum sFas/sFasL in 58 HBV patients and 29 healthy controls. METHODS: HBV patients were categorized into two groups; normal ALT (< or =40 IU/L) and elevated ALT (>40 IU/L). Serum sFas/sFasL levels in HBV patients were measured by ELISA and was compared with those in 29 healthy controls. Serum ALT levels, histological activity, and Fas/FasL expression of liver were compared. RESULTS: Chronic hepatitis B patients with elevated ALT had significantly higher serum sFas levels than those in healthy controls (P<0.01). Serum sFasL levels, however, were significantly lower than those in healthy controls (P<0.01). Patients with moderate to marked degree of inflammation and fibrosis had significantly higher serum sFas levels than those in healthy controls (P<0.05). Serum sFasL levels had no correlation with the hepatic histological activity. Serum sFas/sFasL levels also had no significant correlation with the Fas/FasL expression of liver. CONCLUSIONS: Serum sFas/sFasL levels play a possible role in the pathogenesis of chronic hepatitis B. These results suggest that serum sFas levels might serve as a marker for estimating the degree of hepatic histological activity.
Adult
;
Antigens, CD95/analysis/*blood
;
Fas Ligand Protein/analysis/*blood
;
Female
;
Hepatitis B virus/isolation & purification
;
Hepatitis B, Chronic/*diagnosis
;
Humans
;
Male
;
Middle Aged
3.Expression Patterns of Cytokines and Chemokines Genes in Human Hepatoma Cells.
Eui Cheol SHIN ; Youn Hee CHOI ; Ji Su KIM ; Se Jong KIM ; Jeon Han PARK
Yonsei Medical Journal 2002;43(5):657-664
Various cytokines and chemokines play a role in carcinogenesis. However, no study has previously been undertaken to investigate comprehensively the expressions of cytokines and chemokines in hepatoma cells. In this study, we determined which cytokines and chemokines are expressed in hepatoma cells. Recently, it was reported that the expressions of several chemokines could be increased by Fas stimulus in many normal and cancer cells. Therefore, we also investigated whether chemokines expression is regulated by Fas ligation. To address this issue, we performed RNase protection assays upon 13 cytokines and 8 chemokines genes in 10 human hepatoma cell lines, comprising 8 hepatitis B virus (HBV)-associated hepatoma cell lines. Transforming growth factor-beta2 (TGF-beta2) was found to be expressed in 8 HBV-associated hepatoma cell lines, and to be potently expressed in 5 cell lines; however, the mRNA expressions of interleukin-10 (IL-10), IL-12, interferon-gamma(IFN-gamma) and tumor necrosis factor-alpha(TNF-alpha) were not detected in any cell lines examined. Among the chemokines investigated in this study, IL-8 was expressed by 8 HBV- associated hepatoma cell lines, and monocyte chemoattractant protein-1 (MCP-1) by 7 HBV-associated hepatoma cell lines. However, the mRNA expressions of macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-beta, interferon-inducible protein-10 (IP-10), RANTES, lymphotactin and I-309 were either very weak or undetectable. Fas ligation did not increase chemokines expression in hepatoma cells. Conclusively, TGF-beta2, IL-8 and MCP-1 were overexpressed in HBV-associated hepatoma cells, and the expressions of chemokines were not increased by Fas ligation in human hepatoma cells.
Antigens, CD95/physiology
;
Carcinoma, Hepatocellular/*metabolism
;
Chemokines/*genetics
;
Cytokines/*genetics
;
Gene Expression Profiling
;
Human
;
Liver Neoplasms/*metabolism
;
RNA, Messenger/analysis
;
Tumor Cells, Cultured
4.Gentamicin Induced Apoptosis of Renal Tubular Epithelial (LLC-PK1) Cells.
Kyu Hun CHOI ; Tae Il KIM ; Deug Lim CHONG ; Ho Yung LEE ; Dae Suk HAN
The Korean Journal of Internal Medicine 2000;15(3):218-223
Nephrotoxicity is a major limiting factor in the use of aminoglycoside antibiotics, the mechanisms for which are still speculative. To clarify the mechanisms of renal tubular cell death induced by aminoglycosides, we examined the renal proximal tubule-like cell line, LLC-PK1, after inducing apoptosis through a chronic treatment with gentamicin (GM). Changes in the expression of the Fas were also investigated. On flow cytometric analysis, 5.7 +/- 3.3% of the control cells appeared in a region of decreased forward light scatter and increased side light scatter, where both indices represent the characteristics of apoptotic cell death. Compared to the control, treatment with 10 mM of GM for 15 days significantly increased the proportion of cells in the apoptotic region to 23.9 +/- 8.5%. This finding was supported by electrophoretic analysis of the DNA extracted from the GM-treated cells, where a series of bands corresponding to integer multiples of 180 to 200 base pairs was visualized. However, the 15-day GM treatment did not cause a significant elevation in the expression of the 45 kD Fas protein, the cell surface molecule that stimulates apoptosis, by Western blot analysis. In conclusion, long-term exposure to GM induces apoptosis of the renal tubular epithelial cells, and this process may contribute to some of the aminoglycoside nephrotoxicities. Further studies are needed on the mechanism(s) of apoptosis induced by GM.
Animal
;
Antibiotics, Aminoglycoside/toxicity*
;
Antigens, CD95/analysis
;
Apoptosis/drug effects*
;
Cell Line
;
Gentamicins/toxicity*
;
Kidney Tubules, Proximal/pathology
;
Kidney Tubules, Proximal/drug effects*
;
Swine
5.The Expression of Fas Antigen and Apoptosis in Patients with Myelodysplastic Syndromes and Its Clinical Relevance.
Byung Woo YU ; Kie Ju HAN ; Ji Oh MOK ; Jin Woo JEON ; Sung Kyu PARK ; Jong Ho WON ; Seung Ho BAICK ; Won Suk SUH ; Dae Sik HONG ; Dong Wha LEE ; Hee Sook PARK
Korean Journal of Hematology 1997;32(2):256-265
BACKGROUND: The myelodysplastic syndromes (MDS) are a group of acquired clonal hematopoietic disorders characterized by the peripheral cytopenias and hypercellular or normocellular dysplastic bone marrow. The event responsible for the development of MDS is generally not known. Several recent reports have described an increased frequency of apoptosis in bone marrow cells from patients with aplastic anemia or MDS. Gersuk et al observed that Fas ligand expression was significantly increased on bone marrow cells from MDS patients as compared to normal individuals. METHODS: We examined apoptosis and Fas antigen expression using ISNEL method and immunohistochemistry on marrow cells from 36 patients with MDS. RESULTS: Among the 36 patients, 15 patients (42%) demonstrated apoptosis positive cells (>15%) and 9 patients (25%) demonstrated positive Fas antigen expression (>20%). The presence of apoptosis significantly correlated with hemoglobin level at diagnosis (P<0.05) and the expression of Fas antigen significantly correlated with bone marrow cellularity and CD34 positive cell aggregate group at diagnosis (P<0.05). There was no statistically significant relationship between apoptosis and Fas antigen expression. The median survival of all patients with MDS was 44 months (2-117+). Multivariate analysis showed that FAB classification and hemoglobin level at diagnosis were significant prognostic factor but presence of apoptosis and expression of Fas antigen had no significance. CONCLUSION: The data indicate that the apoptosis and expression of Fas antigen are present in patients with MDS and correlate with some clinical parameters but not significantly associated with survival period of the patients with MDS.
Anemia, Aplastic
;
Antigens, CD95*
;
Apoptosis*
;
Bone Marrow
;
Bone Marrow Cells
;
Classification
;
Diagnosis
;
Fas Ligand Protein
;
Humans
;
Immunohistochemistry
;
Multivariate Analysis
;
Myelodysplastic Syndromes*
6.-Melanocyte Stimulating Hormone (MSH) decreases cyclosporine A induced apoptosis in cultured human proximal tubular cells.
Sang Kyung JO ; So Young LEE ; Sang Youp HAN ; Dae Ryong CHA ; Won Yong CHO ; Hyoung Kyu KIM ; Nam Hee WON
Journal of Korean Medical Science 2001;16(5):603-609
The pathogenesis of chronic cyclosporine A (CsA) nephrotoxicity has not been elucidated, but apoptosis is thought to play an important role in CsA induced tubular atrophy. Recently Fas-Fas ligand system mediated apoptosis has been frequently reported in many epithelial cells as well as in T lymphocytes. We investigated the ability of CsA to induce apoptosis in cultured human proximal tubular epithelial cells and also the effect of -MSH on them. Fas, Fas ligand, and an intracellular adaptor protein, Fas-associating protein with death domain (FADD) expression, and poly-ADP ribose polymerase (PARP) cleavage were also studied. CsA induced apoptosis in cultured tubular epithelial cells demonstrated by increased number of TUNEL positive cells and it was accompanied by a significant increase in Fas mRNA and Fas ligand protein expressions. FADD and the cleavage product of PARP also increased, indicating the activation of caspase. In -MSH co-treated cells, apoptosis markedly decreased with downregulation of Fas, Fas ligand and FADD expressions and also the cleavage product of PARP. In conclusion, these data suggest that tubular cell apoptosis mediated by Fas system may play a role in tubular atrophy in chronic CsA nephrotoxicity and pretreatment of -MSH may have a some inhibitory effect on CsA induced tubular cell apoptosis.
Antigens, CD95/genetics
;
Apoptosis/*drug effects
;
Carrier Proteins/biosynthesis
;
Caspases/physiology
;
Cells, Cultured
;
Cyclosporine/*toxicity
;
Human
;
Immunosuppressive Agents/*toxicity
;
Kidney Tubules, Proximal/cytology/*drug effects/metabolism
;
Membrane Glycoproteins/biosynthesis
;
NAD+ ADP-Ribosyltransferase/metabolism
;
RNA, Messenger/analysis
;
alpha-MSH/*pharmacology
7.Tissue Microarray Analysis of Fas and FasL Expressions in Human Non-small Cell Lung Carcinomas; with Reference to the p53 and bcl-2 Overexpressions.
Journal of Korean Medical Science 2005;20(5):770-776
Lack of surface Fas expression is a main route for apoptotic resistance which is considered an important mechanism of tumorigenesis and tumor progression. Fas and FasL expressions in 110 non-small cell lung carcinomas (NSCLCs) were investigated to evaluate their roles in pulmonary carcinogenesis and to examine the clinicopathologic significance of Fas expression with its relationship with p53 and bcl-2 overexpressions. Immunohistochemical analysis using tissue microarray demonstrated that a large proportion of NSCLC patients (60%) showed lack of membranous Fas expression. The Fas-negative cases revealed the significantly lower survival rate than Fas-positive ones. Also, the loss of Fas receptor expression was found more frequently in advanced stage and higher nodal status. FasL protein was increased in most NSCLCs (89%) compared to normal lungs. p53 and bcl-2 overexpressions showed no association with Fas expression. Conclusively, reduced membranous Fas expression as a mechanism of apoptotic resistance is considered to play an important part of the pulmonary carcinogenesis, which may predict poor survival and have a bad prognostic influence. Increased FasL expression is thought to be a basis for the immune evasion in NSCLCs. The rare bcl-2 overexpression suggests that this anti-apoptotic protein is unlikely to play a role in the apoptotic resistance of NSCLCs.
Antigens, CD95/*metabolism
;
Apoptosis
;
Carcinoma, Non-Small-Cell Lung/*metabolism/mortality
;
Cell Survival
;
Comparative Study
;
Female
;
Gene Expression Profiling
;
Gene Expression Regulation, Neoplastic
;
Humans
;
Korea/epidemiology
;
Lung Neoplasms/*metabolism/mortality/pathology
;
Male
;
Membrane Glycoproteins/*metabolism
;
Middle Aged
;
Oligonucleotide Array Sequence Analysis
;
Prognosis
;
Proto-Oncogene Proteins c-bcl-2/*metabolism
;
Research Support, Non-U.S. Gov't
;
Risk Assessment/methods
;
Risk Factors
;
Survival Analysis
;
Survival Rate
;
Tumor Markers, Biological/*metabolism
;
Tumor Necrosis Factors/*metabolism
;
Tumor Suppressor Protein p53/*metabolism
8.TGF-beta1 inhibition of apoptosis through the transcriptional up-regulation of Bcl-X(L) in human monocytic leukemia U937 cells.
Ju Hie LEE ; Bum Joon PARK ; Jae Hoon PARK ; Moon Ho YANG ; Sung Gil CHI
Experimental & Molecular Medicine 1999;31(3):126-133
To characterize the TGF-beta1 response of monocytic leukemia cells, we analyzed the effects of TGF-beta1 on cell proliferation, differentiation, and apoptosis of human monoblastic U937 cells. Treatment of cells with TGF-beta1 in the absence of growth factors significantly enhanced cell viability. Flow cytometric analysis of DNA content and CD14 expression revealed that TGF-beta1 does not affect cell proliferation and differentiation. Consistent with these results was the finding that no transcriptional induction of Cdk inhibitors such as p21Waf1, p15Ink4b, and p27Kip1 was detected following TGF-beta1 treatment. Interestingly, however, pretreatment of TGF-beta1 significantly inhibited Fas-, DNA damage-, and growth factor deprivation-induced apoptosis. This antiapoptotic effect was totally abrogated by anti-TGF-beta1 antibody. Quantitative RT-PCR analysis demonstrated a dose- and time-dependent transcriptional up-regulation of Bcl-X(L), suggesting its implication in the TGF-1-mediated antiapoptotic pathway. We also observed elevated expression of c-Fos and PTEN/MMAC1. But, no detectable change was recognized in expression of c-Jun, Fas, Fadd, Fap-1, Bcl-2, and Bax. Taken together, our study shows that TGF-beta1 enhancement of cellular viability is associated with its antiapoptotic effect, which may result from the transcriptional up-regulation of Bcl-X(L).
Antigens, CD14/metabolism
;
Antigens, CD95/metabolism
;
Apoptosis/drug effects*
;
Cell Cycle/drug effects
;
Cell Differentiation/drug effects
;
Cell Division/drug effects
;
Cell Survival/drug effects
;
DNA/analysis
;
DNA Damage
;
Gene Expression Regulation, Neoplastic/genetics*
;
Genes, Suppressor, Tumor/genetics
;
Human
;
Leukemia, Myeloid/genetics
;
Neoplasm Proteins/metabolism
;
Phosphoric Monoester Hydrolases/genetics
;
Proto-Oncogene Proteins c-bcl-2/genetics
;
Proto-Oncogene Proteins c-bcl-2/biosynthesis*
;
RNA, Messenger/metabolism
;
Receptors, Antigen, T-Cell/genetics
;
Reverse Transcriptase Polymerase Chain Reaction
;
Signal Transduction
;
Transforming Growth Factor beta/pharmacology*
;
U937 Cells
;
Up-Regulation (Physiology)